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Abstract
It has been known for many years that multiple early life factors can adversely affect lung function 
and future respiratory health.  This is the first systematic review to attempt to analyse all these 
factors simultaneously.  We adhered to strict a priori criteria for inclusion and exclusion of studies.  
The initial search yielded 29,351 citations of which 208 articles were reviewed in full and 25 were 
included in the review.  This included 6 birth cohorts and 19 longitudinal population studies.  The 
25 studies reported the effect of 74 childhood factors (on their own or in combinations with other 
factors) on subsequent lung function reported as percent predicted forced expiration in one 
second (FEV1).  The childhood factors that were associated with a significant reduction in future 
FEV1 could be grouped as: early infection, bronchial hyper-reactivity (BHR) / airway lability, a 
diagnosis of asthma, wheeze, family history of atopy or asthma, respiratory symptoms and
prematurity / low birth weight. A complete mathematical model will only be possible if the raw 
data from all previous studies is made available.  This highlights the need for increased 
cooperation between researchers and the nee  for international consensus about the outcome 
measures for future longitudinal studies.   
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Introduction
The two respiratory diseases with the largest burden on patients and on society as a whole are 
asthma and chronic obstructive pulmonary disease (COPD). Both have their origins in early  
childhood.[1–4].  The early life factors that have been implicated in poor future lung health include
environmental tobacco smoke, antenatal nutrition, premature birth, respiratory infections in early 
life, air pollution, social deprivation, obesity and asthma.[5–8] To reduce the global burden of 
respiratory disease we should target modifiable early life factors known to be associated with 
subsequent respiratory disease.  
The purpose of this review was to (a) systematically assess early life factors which have been 
reported in association with low lung function and if the data allowed (b) develop a mathematical 
model to simultaneously assess the relative contribution of each factor. Studies are limited in 
which subjects exposed to risk factors early in life have had lung function measured into early or 
later adult life.  Despite this, observational cohort studies have demonstrated “tracking” of low 
lung function in early childhood through adolescent years [9,10] and into adult life.[11]  The 
assumption that children with reduced lung function will continue to have poor respiratory health 
is supported by the Melbourne Asthma Cohort in that those with severe asthma added to the 
study at the age of 10 years already then demonstrating low lung function, were much more likely 
to develop COPD by 55 years of age.[12,13]  
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Aims
There have been no comprehensive systematic reviews on this important area.  We undertook this 
review to address this omission.  The aims of our review were:
1. Systematically review the medical literature to identify longitudinal, observational studies 
reporting associations between known early life risk factors for poor future respiratory 
health and lung function.
2. Undertake statistical analysis to quantify the size effects of those risk factors on lung 
function.  
3. If possible, to develop a mathematical model to simultaneously assess the relative 
contribution of each risk factor together with any interactions.
Methodology
To ensure that the temporal association between putative risk factors and lung function was 
consistent with a causal relationship, an a priori decision was made to exclude cross-sectional 
studies.[14]   Only longitudinal studies which estimated the association of a factor or factors 
ascertained before forced expiratory volume in one second (FEV1) was measured were included. 
By definition systematic reviews involving lung function are required to select a single index to 
enable comparison between studies.  Forced expiratory volume in one second (FEV1) 
measurements have been the most widely reported and best understood lung function indices in 
the paediatric medical literature.  They can be reported as FEV1 volume, percentage predicted 
FEV1, FEV1 z scores or FEV1: forced vital capacity (FVC) ratios.  No individual measure is perfect but 
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it is necessary to correct for growth, gender, ethnicity and age when combining studies which 
involve children.  It was therefore decided a priori to use percentage predicted FEV1 as our end 
point. 
A search of Medline, using the search strategy described in Appendix S1 (Date for search – from 
1946 up until October 2014; Type of studies – Human. Language – English), was performed and
papers identified were imported into Reference Manager (Thomson Reuters, Carlsbad, CA).  After 
removal of duplicate papers, titles and abstracts of all identified studies were screened by two 
independent reviewers (AK and VB) to select publications that met the following 3 criteria:
1. They included COPD and/or asthma
2. They were longitudinal population-based cohorts recruited at birth or in early 
childhood (<5 years of age).
3. Lung function was measured after assessment of exposure to early life risk factors.
Where there was uncertainty as to whether all 3 criteria were met, the full article was obtained
and scrutinised. Disagreement between reviewers was resolved by discussion between AK and VB
and, if necessary, a third person (AP) acted as arbitrator.  
The remaining papers that were relevant to the research question were obtained and screened to 
discover if all the following data were available:
4. Early life exposure to a defined risk factor.
5. Lung function reported as percent predicted FEV1 or data available from which this 
index could be derived.   
6. FEV1 data (mean and standard deviation [SD] or 95% confidence intervals [CI] or 
standard error of measurement [SEM] or median and interquartile range [IQR]) were 
reported separately for subjects exposed and non-exposed to the relevant risk factors.
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The authors of the papers excluded from this review (n=30), because they did not meet criteria 4-
6, were contacted and asked if they were willing to provide data to enable their inclusion.
Quality assurance
The methodological quality of the studies was formally assessed using a quality assurance tool
from the Critical Appraisal Skills Programme (CASP) (http://www.casp-uk.net/#!casp-tools-
checklists/c18f8) which consists of nine questions.[15] See Box 1. Each question could be 
answered “Yes”, “No” or “Do not know”. If the answer was “Yes” a score of 1 was given and if the 
answer was “No” a score of 0 was given. If the answer was “Do not know” the original authors 
were contacted for clarification. If a clarification was provided the previous scoring rule was 
applied. If clarification was not available then a score of 0 was given. Each study therefore had a 
quality assurance score out of nine.  The questions that were most relevant when assessing the 
quality of longitudinal-cohort and birth-cohort studies were 1,2,3,5,6,7.   Studies were only 
selected if the answer was “yes” to all these questions.
Box 1: Critical Appraisal Skills Programme Questions
1. Were the factors that affected lung function clearly described? 
2. Was a method of screening used to confirm exposure to factor(s)? 
3. Did the study have a control cohort? 
4. Was there confirmation that the control cohort had no exposure to any of the risk factors? 
5. Were the measures used appropriate? 
6. Were one or more measurements taken at a defined time point in both groups?  
7. Were both point measures (e.g. mean/median) and measures of dispersion (e.g. SD, IQR, 
etc.) reported at each measurement point? 
8. Were drop-out rates reported? 
9. Were all important confounding factors identified?
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Data extraction and synthesis
For each paper, differences between the means of the percent predicted FEV1 and the 95% CI of 
the difference between the exposed and unexposed sample were calculated for each risk factor
using the formula below. Unequal variance was assumed.[16]
Box 2: Calculation of Mean Difference
Key: MD – Mean Difference; 95% CI – 95% Confidence Interval; t’(1-α/2) – reliability factor estimated 
using the previously described procedure [16]; and was estimated  s1 – Standard deviation of the 
predicted FEV1 in the exposed population; n1 – Sample size of the exposed population; s2 –
Standard deviation of the predicted FEV1 in the non-exposed population; n2 – Sample size of the 
non-exposed population.
When the SEM was given, the SD was estimated by multiplying the SEM by the square root of the 
number of participants in the group.  When median and IQR were presented the mean was 
estimated to be equal to the median and the SD was estimated to be the inter quartile range 
divided by 1.35.[16]
A structured approach was used to assess if the data available in the selected articles allowed for a 
mathematical model to be developed. This is described below. The risk factor reported in each 
paper was identified as a binary outcome, once this was done the corresponding percent 
predicted FEV1 data for those exposed and those not exposed was documented for every 
measurement time point.   It is important to note that there were missing values (i.e. not all risk 
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factors had a measure taken at every reported time point). Where missing values were identified 
we contacted respective authors to provide us with the required data.  
Results
The initial search yielded 29,351 citations. After removal of duplicates and screening for relevance,
208 articles were selected for full review, of which 55 met the inclusion criteria (criteria 1-3 
above). Twenty five studies met additional inclusion criteria (4-6 above), thus enabling 
comparison between papers.  See Figure 1.  They comprised 6 birth cohorts[17–22] and 19 
population-based longitudinal studies.[12,13,23–39] Tables 1 and 2 give an overview of the 
included studies.  The reasons for rejecting the remaining 30 papers [9,10,40–67] are summarised 
in Table 3. When the 25 selected articles were analysed, the published data were not suitable for 
the development of an explanatory model.  All relevant authors were contacted but no additional 
data were made available.
Figure 1: PRISMA flowchart showing numbers of articles reviewed for the systematic review
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Table 1: Summary of birth cohort studies included in systematic review
Article Factors Investigated Sample size FEV1 Measured Quality
Assurance Score
Collins 20-11 [17] Asthma at 6-14 years
Atopy at 6-14 years
BHR at 6-14 years
1510 6 - 14 years 8/9
Grischkan 2004 
[18]
Prematurity
Asthma at 8-11 years
251 8 - 11 years 8/9
Guilbert 2011 [19] Parental allergy and asthma
Wheezing <3years
238 5 - 8 years 8/9
Hollams 2014 [20] Maternal smoking in pregnancy 
Smoking at age 14 years
1129 14 years 8/9
Mullane 2013 [21] Lung function at 1 month
Wheezing at 18 years
150 18 years 7/9
Vonk 2004 [22] LRTI aged <1year
BHR / atopy 20 years
597 20 years 8/9
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Table 2: Summary of Longitudinal Studies included in systematic review
Article Factors Investigated Sample size FEV1 
Measured
Quality
Assurance
Score
Cassimos 2008 [23] Bronchiolitis < 1year
Asthma at 7.5 years
189 7.5 years 7/9
De Goojer 1993 [24] Family history of atopy
Respiratory symptoms 8-11 years
60 8-11 years
36 years
8/9
Goksor 2007 [25] Pre / post-natal smoke exposure
Hospitalised with wheeze <2 years
101 17-20 years 7/9
Goksor 2008 [26] Pre / post natal smoke exposure
Asthma 17-20 years
101 17-20 years 8/9
Kim 2013 [27] History of bronchiolitis
Exposure to high levels of ozone
1743 6.8 years 7/9
Korppi 2004 [28] RSV bronchiolitis <2 years 127 18-20 years 7/9
Kwinta 2013 [29] Extreme low birth weight
Wheeze
81 6.7 years 8/9
Mai 2003 [30] Prematurity <36 weeks 138 12 years 7/9
Mikalsen 2012 [31] Bronchiolitis < 1 year
RSV +’ve / RSV –‘ve
Asthma at 11 years
121 11 years 6/9
Murray 1992 [32] Clinical bronchiolitis <1 year 73 5 years 7/9
Oswald 1997 [33] Mild wheezy bronchitis at 7 years
Wheezy bronchitis at 7 years
Asthma at 7 years
Severe asthma at 7-10 years
286 35 years 6/9
Piippo-Savolainen 
2004 [34]
Hospitalised with bronchiolitis <2 years
Hospitalised with pneumonia <2 years
88 18-21 years 7/9
Rasmusen 2000 [35] Airway lability at 14 years
Airway lability at 19 years
271 14-19 years 7/9
Sigurs 2005 [36] RSV < 6 months 47 13 years 7/9
Siltanen 2004 [37] Preterm (<34 weeks) and BW <1.5 kg 72 10 years 8/9
Tai 2014 [12] Mild wheezy bronchitis at 7 years
Wheezy bronchitis at 7 years
Asthma at 7 years
Severe asthma at 7-10 years
197 50 years 8/9
Tai 2014 [13] Wheezy bronchitis and asthma 7 years
Asthma readmission at 50 years
Asthma at 50 years
COPD at 50 years
197 50 years 8/9
Tamesis 2013 [38] Doctor diagnosis of asthma at 7 years
BHR at 7 years
Asthma at 7years
177 7 years 7/9
Wilson 2004[39] Atopic parent
Wheeze <4 years
Wheeze >4 years
49 10 years 8/9
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Table 3: Summary of studies that were rejected
Article Factors Investigated Lung 
Function 
Reason for 
Rejection
Castro-Rodríguez 
2001 [9]
Lower respiratory illness in first 3 years 6 & 11 years 1
Castro-Rodríguez 
2001 [10]
Asthma symptoms, BMI and skin tests at 6 years 11 years 1
Stein 1999 [40] Lower respiratory tract illness in first 3 years Up to 13 
years
1
Krantz 1990 [41] Whooping cough as infant 6-13 years 1
Bisgaard 2012 [42] BHR as neonate 6 years 1
Kurukulaaratchy 2003
[43]
BHR at 1,2,4 & 10 years 10 years 1
Lodge 2014 [44] Wheeze phenotypes, asthma and respiratory symptoms 12 & 18 years 1
Narang 2008 [45] Preterm delivery 21 years 1
Pike 2013 [46] Asthma, wheeze and atopy at 6, 12 ,24 & 36 months 6 years 1
Illi 2006 [47] Allergen exposure at 6 & 18 months and 3, 4 & 5 years 7, 10 & 13 
years
1
Granell 2013 [48] Early wheezing phenotypes, doctor-diagnosed asthma 
and atopy at 7 years
8 years 1
Kreiner-Moller 2013
[49]
Diagnosis of asthma 6 years 1
Pike 2012 [50] Wheeze phenotype at 6, 12, 24 & 36 months. 
Infant adiposity gain 0-6 months.
6 years 1
Ware 1984 [51] Exposure to indoor and outdoor air pollutants 1
Morales 2014 [52] Intrauterine and early postnatal exposure to outdoor air 
pollution
4 years 1
Torjussen 1992 [53] Exposure to environmental tobacco smoke and pets 10 years 1
Chen 2014 [54] Physical fitness, sedentary time, obesity measures and 
asthma aged 9 to 12 years
9 to 12 years 2
Singleton 2003 [55] Hospitalised with RSV at <2 years 5 & 8 years 2
Martinez 1995 [56] Wheezing phenotypes, markers of atopy 6 years 2
Turner 2009 [57] Airway responsiveness at 1, 6 & 12 months. 
Asthma at 11 years
11 years 2
Chawes 2010 [58] Asthma, eczema, food sensitization, markers of atopy 
and bronchial responsiveness
7 years 2
Hallberg 2010 [59] Presence of asthma at 1, 2, 4 and 8 years 8 years 2
Eenhuizen 2013 [60] Long-term average air pollution concentrations 4 years 2
Van der Gugten 2013
[61]
Respiratory symptoms and presence of respiratory 
viruses 
<1 year 2
Voraphani 2014 [62] RSV LRTI < 3 years 26 years 2
Belgrave 2014 [63] Wheeze and atopy phenotypes at 3, 8 & 11 years 3, 8 & 11 
years
2
Elliott 2013 [64] Wheeze phenotypes 0-1 & 2-3 
years
2
Wills 2013 [65] 25(OH)D concentrations in pregnancy. Wheeze, asthma, 
atopy, eczema, hayfever, at 7-8 years  
9 years 3
Kerkhof 2014 [66] Environmental tobacco smoke 6-8 years 3
Halonen 2013 [67] Eczema and wheezing < 1 year, physician-diagnosed 
asthma <9 years and asthma in the parents
9 years 3
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Reason for rejection: 1- Data not presented as percent predicted FEV1
2- Data not presented as FEV1
3- Missing data
All 25 selected papers answered “Yes” to the six key quality questions (1,2,3,5,6,7).  The total 
quality score for each paper can be seen in Tables 1 and 2.  Although the risk of bias was minimal it 
was not eliminated as it was not possible to clearly identify potential confounding factors 
(questions 4 & 9) in all papers selected.  
The 25 papers included in the review reported the association of 74 childhood factors (either 
individually or in combination) together with subsequent percent predicted FEV1.    Full details of 
these exposures are shown in Appendix 2.  A number of childhood factors were associated with a 
significant reduction in subsequently measured FEV1 as defined by the 95% CI of the mean 
difference (MD) from unexposed subjects excluding zero.  These factors could be broadly grouped 
into: early childhood infection, bronchial hyper-responsiveness (BHR) / airway lability, wheeze, 
family history of atopy or asthma, a diagnosis of asthma, respiratory symptoms and prematurity / 
low birth weight.  The childhood factors that were significantly associated with future lung 
function are summarised in Figure 2.
Figure 2: Summary of childhood factors associated with a significant reduction in subsequent 
lung function
Discussion
Although it is widely recognised that a number of early life factors can adversely affect lung 
function and therefore future respiratory health [1–4], to our knowledge this is the first 
comprehensive, systematic review on this topic.  A number of risk factors including early childhood 
infection, BHR / airway lability, a childhood diagnosis of asthma, wheeze, family history of atopy or 
asthma, respiratory symptoms and prematurity / low birth weight were associated with low 
percent predicted FEV1 when measured later in childhood or in adult life in some but not all of the 
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papers identified.  These were variously reported individually or in combination with other factors. 
The most frequently reported data were for childhood infection, BHR / airway lability and a 
childhood diagnosis of asthma.  
We adhered to strict a priori inclusion and exclusion criteria for studies.  This strengthened our 
results but necessitated the exclusion of some potentially informative studies.  Cross-sectional 
studies were excluded as they cannot assess the temporal direction of associations, making the
inference of causality impossible.  The quality assurance tool confirmed that the included studies 
were of a high quality with a low risk of bias.  Despite this, we were not able to fully quantify the 
risk of bias associated with confounders (in both the study and the control cohorts) or with 
missing values as these were not always documented.  
A priori we chose percent predicted FEV1 as the outcome measure and therefore excluded studies 
that did not report this value or provide the raw data to allow its calculation.  This decision was 
subsequently justified as it was the most frequently reported lung function outcome measure in 
the relevant studies.  We accept that percent predicted FEV1 is not the perfect lung function 
outcome.  The equations used to generate the percentage values can impact on results.[68]  It 
may also be less sensitive than Lung Clearance Index in detecting early lung disease [69] and not 
be as accurate as FEV1 z scores.  Unfortunately, neither of these outcome measures has been used 
in many longitudinal studies.   
It might be assumed that environmental tobacco smoke before birth, and in the early years of life,
is a very important risk factor for future respiratory health.  Indeed, there are many studies 
culminating in a systematic review by Cook et al. (1998) which concluded that maternal smoking 
was associated with a small but statistically significant deficit in lung function in school aged 
children.[6] Unfortunately, most studies included in that review were cross-sectional and the
longitudinal studies included did not present data as percent predicted FEV1.   None of those 
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studies therefore met our inclusion criteria.   The effects of maternal smoking on lung function are
mainly seen in early childhood, the differences becoming less apparent with time.  There has been
a similar debate about the possible effects of environmental pollution and lung growth but 
relevant papers were not included in our review as they were cross-sectional or did not provide 
outcome data as percent predicted FEV1. The seminal paper on lung growth and pollution showed 
adverse effects on lung development in children 10 to 18 years old leading to clinically significant 
deficits in attained FEV1 as they reached adulthood.[70] In addition, 2 large paediatric [71,72] and 
one adult study[73] have identified small deficits in lung function associated with exposure to
particulate matter.  
In our study 7 of 22 risk factor combinations which included early childhood infections were
associated with a low percent predicted FEV1 in later life.  Acute viral bronchiolitis and viral 
illnesses associated with wheeze in young children are common but the terminology used to 
define them is variable.  Two  combinations which included early childhood infection had very 
wide confidence intervals (ID 43 & 45) suggesting there were other unexplored confounding 
factors contributing to the observed differences. In some studies early respiratory viral infections 
have been associated with the subsequent development of asthma [23,32,34,36] but not in 
others.[40,74]  It has been suggested that RV infections in early life are more likely to cause 
reduced lung function than RSV infections.[19]  Birth cohort studies suggest that lung damage 
caused by infection may be dependent on the lung already being abnormal due to genetic, 
immunological or developmental issues as identified by reduced lung function at birth.[40,75,76]
This suggests that other risk factors such as prematurity may interact with early infection.    
Seven of 8 risk factor combinations that included BHR or airway lability showed a significant 
reduction in percent predicted FEV1.  Although not present in all patients, BHR is an important 
feature of asthma and it may also contribute to COPD phenotype.[77]  It is caused by an influx of 
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inflammatory cells and improves when  treated with inhaled corticosteroids.[78]  The triggers can 
be nonspecific such as viral infections or specific such as allergen inhalation.  The exact 
relationship between BHR in childhood and the later development of respiratory disease (with or 
without BHR) is unclear.  Some articles included in our review investigated the association 
between childhood asthma and the subsequent development of COPD.[17,18,23,26,31,33]  Six of 
13 risk factor combinations included in these articles had a significant reduction in percent 
predicted FEV1.  We had envisaged including more long term asthma cohort studies within our 
review but most have not measured FEV1 percent predicted.  The paediatric asthma study with the 
longest duration of follow-up is from Melbourne, which reported FEV1 percent predicted at 50 
years with a number of participants having been diagnosed with COPD.[12,13]  The vast majority
of those with COPD aged 50 years came from the severe asthma group recruited at 10 years of 
age.    
Prematurity and extreme prematurity have been highlighted as risk factors for reduced lung 
function in childhood and for increased severity of viral respiratory infections in infancy.  Four
studies were included in our review .Three of the five risk factor combinations investigated 
showed a significant association with subsequent low lung function.[18,29,30,37]  The longest 
duration of follow-up in those  studies was 12 years.  A 21 year follow-up study of babies born 
extremely prematurely has reported that any differences in lung function compared with term-
born controls during childhood disappears in adult life.[45]  This may be linked to suggestions from 
recent imaging studies that alveolarisation continues through to adolescence.[79] Although 
studies included in our review did not show lower FEV1 in atopic compared with non-atopic
children, the Multicentre Allergy Study (not included as did not present data on percent predicted 
FEV1) found that 90% of children with wheeze but no atopy lost their symptoms at school age and 
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retained normal lung function at puberty.  In contrast, those sensitised to perennial allergens in 
the first 3 years of life had reduced lung function at school age.[47]
We began this review with the aim of prioritising factors in early life which adversely affect lung 
function and future lung health. We chose FEV1 percent predicted as our outcome measure as this 
was the most widely reported lung function measurement. We soon realised, however, that the
data on FEV1 were much more limited than we had hoped.  We also recognised that many risk
factors for subsequent low FEV1 were not reported as independent variables.  Therefore a
complex picture began to emerge in which multiple factors interacted to affect subsequent lung 
function. Such interactions have not previously been well discussed.  An example of this is early 
childhood infection.  In isolation, acute viral infections in infancy are associated with subsequent 
low FEV1 values but the incidence and severity of such infections are affected by other factors such 
as prematurity, social deprivation, atmospheric pollution and secondary tobacco smoke exposure.   
In turn, prematurity may be influenced by maternal diet, socio-economic status, maternal smoking 
and a host of genetic and epigenetic factors, some of which are not fully understood.  This 
complex web of interactions means it is almost impossible to quantify the effect of a single 
childhood risk factor for future respiratory health.  It also suggests it is impossible or impractical to 
design and implement a sufficiently rigorous birth cohort study to model this outcome.[80]  
Conclusion
This systematic review has confirmed that a number of childhood factors significantly adversely 
affect subsequent lung function.  These include: early infection, BHR / airway lability, asthma, 
wheeze, a family history of atopy or asthma, respiratory symptoms and prematurity / low birth 
weight {Figure 2}.  The different outcome measures reported by cohort studies and our inability to 
obtain their raw data meant that it was not possible to develop a mathematical model to prioritise 
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the effects of the various early life factors.  The interaction between these factors means that any 
such model would be extremely complex.   If we are to further elucidate the role of early 
childhood factors that affect future respiratory health it essential that the data from all previous 
studies are made freely available.[81]  Collaborations to share the data from cohort studies such 
as the Study Team for Early Life Asthma Research (STELAR)[82] represent an important new 
direction for future research.  
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Figure 1: PRISMA flowchart showing numbers of articles reviewed for the systematic review
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Figure 2: Summary of childhood factors associated with a significant reduction in subsequent 
lung function
RSV: Respiratory syncytial virus, RV: Rhinovirus, BHR: bronchial hyper-responsiveness
